Fig. 2From: Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysisSurvival rates at 4, 12, and 48 weeks for TDF and ETV in all included studiesBack to article page